Align Technology, Inc. vs Global X NASDAQ 100 Covered Call ETF — how do they compare? Align Technology, Inc. trades at $180.83 (market cap $12.86B), while Global X NASDAQ 100 Covered Call ETF trades at $18.14. The key difference: Global X NASDAQ 100 Covered Call ETF is trading nearer its 52-week high, Align Technology, Inc. nearer its low. Which is the better fit depends on your goals.
| ALGN | QYLD | |
|---|---|---|
Market Cap | $12.86B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $207.19 | $18.52 |
52-Week Low | $124.88 | $16.46 |
Enterprise Value | $11.92B | — |
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
QYLD trades at $18.46, up 0.38% today, with a bullish technical signal from moving averages but neutral oscillators. The ETF's strategy of selling covered calls on the Nasdaq-100 provides high monthly dividends, but long-term performance has lagged the index's growth. Recent news highlights concerns over NAV erosion despite the 12% yield.
The outlook for QYLD is mixed: it offers high income for retirees but faces structural headwinds in bull markets due to capped upside. Risks include underperformance versus the Nasdaq-100 and reliance on options premiums. Investors seeking steady cash flow may find value, but total return potential remains constrained.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →QYLD is an ETF that follows a covered call strategy on the NASDAQ 100 Index. The fund holds a long position in the stocks of the NASDAQ 100 and simultaneously writes (sells) call options on the index. The primary goal is to generate monthly income from the option premiums. This strategy can reduce portfolio volatility and provide income, but it limits potential capital appreciation from a significant rise in the NASDAQ 100 Index.
Read more on QYLD →